Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial
Olivier Trédan, Damien Pouessel, Nicolas Penel, Sylvie Chabaud, Carlos Gomez‐Roca, Jean-Pierre Delord, Diane Pannier, Mehdi Brahmi, Michel Fabbro, Marie-Eve Garcia, Delphine Larrieu‐Ciron, Isabelle Ray‐Coquard, Marie Viala, Antoîne Italiano, Diégo Tosi, Philippe A. Cassier, Armelle Dufresne, Valéry Attignon, Sandrine Boyault, Isabelle Treilleux, Alain Viari, David Pérol, Jean Yves Blay (2025). Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial. , 31(5), DOI: https://doi.org/10.1038/s41591-025-03613-x.
Article19 days agoIncreasing targeted therapy options for patients with relapsed cancer with broader somatic gene panel analysis from the primary tumor: The Profiler02 randomized phase II trial.
Olivier Trédan, Damien Pouessel, Nicolas Penel, Sylvie Chabaud, Carlos Gomez‐Roca, Diane Pannier, Mehdi Brahmi, Michel Fabbro, Marie-Eve Garcia, Delphine Larrieu‐Ciron, Isabelle Laure Ray-Coquard, Marie Viala, Antoîne Italiano, Philippe A. Cassier, Armelle Dufresne, Valéry Attignon, Isabelle Treilleux, Alain Viari, David Pérol, Jean Yves Blay (2022). Increasing targeted therapy options for patients with relapsed cancer with broader somatic gene panel analysis from the primary tumor: The Profiler02 randomized phase II trial.. , 40(16_suppl), DOI: https://doi.org/10.1200/jco.2022.40.16_suppl.3130.
Article16 days agoEE608 Cost Effectiveness Analysis of a Large (Foundation Medicine) Versus a Home-Based Medium Gene Panel for Exome Sequencing: Results of the Profiler 02 Randomized Clinical Trial
Lionel Perrier, Olivier Trédan, M. Morelle, Nicolas Penel, P. Fournel, L Greillier, François Ghiringhelli, Diégo Tosi, François Bertucci, M. Campone, J.P. Delord, Damien Pouessel, G. Garin, Sylvie Chabaud, C Gomez-Roca, Diane Pannier, Mehdi Brahmi, Michel Fabbro, ME Garcia, I. Ray-Coquard, Marie Viala, Antoîne Italiano, Philippe A. Cassier, Armelle Dufresne, Valéry Attignon, Isabelle Treilleux, Alain Viari, Thibault De La Motte Rouge, Xavier Durando, David Pérol, Jean Yves Blay (2022). EE608 Cost Effectiveness Analysis of a Large (Foundation Medicine) Versus a Home-Based Medium Gene Panel for Exome Sequencing: Results of the Profiler 02 Randomized Clinical Trial. , 25(12), DOI: https://doi.org/10.1016/j.jval.2022.09.847.
Article14 days agoAbstract CT025: Dabrafenib plus trametinib in BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG)
Vivek Subbiah, Alexander Stein, Martin J. van den Bent, Antje Wick, Filip De Vos, Nikolas von Bubnoff, Myra E. van Linde, Albert Lai, Gerald W. Prager, Mario Campone, Angelica Fasolo, José A. López-Martín, Tae Min Kim, Ralf‐Dieter Hofheinz, Jean Yves Blay, Daniel C. Cho, Anas Gazzah, Damien Pouessel, Jeffrey Yachnin, Aislyn Boran, Paul Burgess, Palanichamy Ilankumaran, Eduard Gasal, Patrick Y. Wen (2021). Abstract CT025: Dabrafenib plus trametinib in BRAF V600E-mutant high-grade (HGG) and low-grade glioma (LGG). , 81(13_Supplement), DOI: https://doi.org/10.1158/1538-7445.am2021-ct025.
Article14 days ago